Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.
Vinod AroraRajan VijayaraghavanRakhi MaiwallAmrish SahneySherin Sarah ThomasRehmat AliPriyanka JainGuresh KumarShiv Kumar SarinPublished in: Hepatology (Baltimore, Md.) (2020)
PICD is common and develops even with MVP in ACLF patients. Albumin infusion decreases the incidence of PICD and mortality in patients with ACLF. Clinical trial identifier: NCT02467348.
Keyphrases
- liver failure
- clinical trial
- hepatitis b virus
- end stage renal disease
- low dose
- drug induced
- risk factors
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- oxidative stress
- prognostic factors
- cardiovascular events
- randomized controlled trial
- respiratory failure
- cardiovascular disease
- type diabetes
- diabetic rats
- intensive care unit
- patient reported outcomes
- double blind